Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
2(40.0%)
5Total
N/A(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03051997Not ApplicableCompleted

Increasing Caregiver Engagement in Juvenile Drug Courts

Role: collaborator

NCT05352568Not ApplicableCompleted

Is Cognitive Training an Option?

Role: lead

NCT02339363Phase 1Completed

Effects of Sitting Meditation and Hatha Yoga in Adolescents

Role: lead

NCT01594593Not ApplicableCompleted

Acceptance-Based Treatment for Prostate Cancer Distress

Role: collaborator

NCT01187784Phase 1Completed

Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and Anxiety

Role: lead

All 5 trials loaded